Agilent Technologies (NYSE:A) Updates FY 2025 Earnings Guidance

Agilent Technologies (NYSE:A) updated its FY 2025 earnings guidance on Monday. The company provided earnings per share guidance of 5.540-5.610 for the period, compared to the consensus earnings per share estimate of 5.660. The company issued revenue guidance of $6.8 billion-$6.9 billion, compared to the consensus revenue estimate of $6.8 billion. Agilent Technologies also updated its FY25 guidance to $5.54-5.61 EPS.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Wells Fargo & Company began coverage on Agilent Technologies in a report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 target price for the company. UBS Group upped their price target on Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. JPMorgan Chase & Co. reduced their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday. Citigroup upped their price target on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Finally, Barclays upped their price target on Agilent Technologies from $135.00 to $145.00 and gave the stock an “underweight” rating in a research report on Tuesday, October 15th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $144.07.

Agilent Technologies Price Performance

Shares of A opened at $134.35 on Wednesday. The business’s 50-day moving average is $137.74 and its two-hundred day moving average is $137.43. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. Agilent Technologies has a fifty-two week low of $124.10 and a fifty-two week high of $155.35. The company has a market capitalization of $38.60 billion, a P/E ratio of 27.87, a P/E/G ratio of 5.89 and a beta of 1.07.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.248 per share. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a dividend yield of 0.74%. The ex-dividend date of this dividend is Tuesday, December 31st. Agilent Technologies’s dividend payout ratio is presently 19.50%.

Insider Transactions at Agilent Technologies

In related news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This trade represents a 19.98 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.